Jamie Raskin's Low Opinion of Women
Thank You, GOD!
Trump Slams Bad Bunny's Horrendous Halftime Show
Federal Judge Sentences Abilene Drug Trafficker to Life for Fentanyl Distribution
The Turning Point Halftime Show Crushed Expectations
Jeffries Calls Citizenship Proof ‘Voter Suppression’ as Majority of Americans Back Voter I...
Four Reasons Why the Washington Post Is Dying
Foreign-Born Ohio Lawmaker Pushes 'Sensitive Locations' Bill to Limit ICE Enforcement
TrumpRx Triggers TDS in Elizabeth Warren
Texas Democrat Goes Viral After Pitting Whites Against Minorities
U.S. Secret Service Seized 3 Card Skimmers in Alabama, Stopping $3.1M in Fraud
Jasmine Crockett Finally Added Some Policy to Her Website and It Was a...
No Sanctuary in the Sanctuary
Chromosomes Matter — and Women’s Sports Prove It
The Economy Will Decide Congress — If Republicans Actually Talk About It
Tipsheet
Premium

Moderna CEO Offers Prediction for When Pandemic Could Be Over

AP Photo/Rogelio V. Solis

We've heard many predictions over the last 18 months about the coronavirus pandemic, including timetables for when it can officially be considered "over" due to herd immunity from natural infection and widespread vaccination. 

Now, the CEO of Moderna Stephane Bancel has weighed in with his thoughts on when the pandemic will be over on a global level. 

"If you look at the industry-wide expansion of production capacities over the past six months, enough doses should be available by the middle of next year so that everyone on this earth can be vaccinated. Boosters should also be possible to the extent required," Bancel told the Swiss newspaper Neue Zuercher Zeitung, Reuters reports. 

"Those who do not get vaccinated will immunize themselves naturally, because the Delta variant is so contagious," he continued. "In this way we will end up in a situation similar to that of the flu. You can either get vaccinated and have a good winter. Or you don't do it and risk getting sick and possibly even ending up in hospital." 

Asked if that meant a return to normal in the second half of next year, he said: "As of today, in a year, I assume."

Bancel said he expected governments to approve booster shots for people already vaccinated because patients at risk who were vaccinated last autumn "undoubtedly" needed a refresher.

Its booster shot had half the dose of the original dose, which meant more of them would be available.

"The volume of vaccine is the biggest limiting factor. With half the dose, we would have 3 billion doses available worldwide for the coming year instead of just 2 billion," he said. (Reuters)

Bancel said the company is conducting clinical trials for "Delta-optimized variants," which would be available for booster vaccinations in 2022. They're also testing "Delta plus Beta, the next mutation that scientists believe is likely." 

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement